STOCK TITAN

Leidos Holdings, Inc. Reports Second Quarter Fiscal Year 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Leidos Holdings (NYSE: LDOS) reported strong Q2 FY2024 results, with revenues up 8% year-over-year to $4.1 billion. Net income increased 54% to $324 million, or $2.37 per diluted share. Adjusted EBITDA grew 33% to $559 million, with a record margin of 13.5%. Non-GAAP diluted EPS rose 46% to $2.63.

The company generated $374 million in operating cash flow and $351 million in free cash flow. Net bookings totaled $4.0 billion, resulting in a book-to-bill ratio of 1.0. Leidos updated its FY2024 guidance, raising the adjusted EBITDA margin to approximately 12% and non-GAAP diluted EPS to $8.60-$9.00.

Leidos Holdings (NYSE: LDOS) ha riportato risultati solidi per il secondo trimestre dell'anno fiscale 2024, con ricavi in aumento dell'8% rispetto all'anno precedente, raggiungendo $4,1 miliardi. L'utile netto è aumentato del 54% a $324 milioni, ovvero $2,37 per azione diluita. L'EBITDA rettificato è cresciuto del 33% fino a $559 milioni, con un margine record del 13,5%. L'EPS diluito non-GAAP è aumentato del 46% a $2,63.

La società ha generato $374 milioni di flusso di cassa operativo e $351 milioni di flusso di cassa libero. Gli ordini netti hanno totalizzato $4,0 miliardi, portando a un rapporto book-to-bill di 1,0. Leidos ha aggiornato la propria guida per l'anno fiscale 2024, aumentando il margine EBITDA rettificato a circa il 12% e l'EPS diluito non-GAAP a $8,60-$9,00.

Leidos Holdings (NYSE: LDOS) informó resultados sólidos para el segundo trimestre del año fiscal 2024, con ingresos que aumentaron un 8% interanual, alcanzando $4.1 mil millones. El ingreso neto aumentó un 54% a $324 millones, o $2.37 por acción diluida. El EBITDA ajustado creció un 33% a $559 millones, con un margen récord del 13.5%. El EPS diluido no-GAAP aumentó un 46% a $2.63.

La compañía generó $374 millones en flujo de caja operativo y $351 millones en flujo de caja libre. Los pedidos netos totalizaron $4.0 mil millones, resultando en una relación book-to-bill de 1.0. Leidos actualizó su guía para el año fiscal 2024, elevando el margen de EBITDA ajustado a aproximadamente el 12% y el EPS diluido no-GAAP a $8.60-$9.00.

Leidos Holdings(NYSE: LDOS)는 2024 회계연도 2분기 실적이 강세를 보였다고 보고하며, 수익이 전년 대비 8% 증가한 $41억에 달했습니다. 순이익은 54% 증가하여 $3억 2400만, 즉 주당 희석 기준 $2.37에 달했습니다. 조정된 EBITDA는 33% 성장하여 $5억 5900만에 도달했으며, 기록적인 13.5%의 마진을 기록했습니다. 비-GAAP 희석 EPS는 46% 증가하여 $2.63에 도달했습니다.

회사는 $3억 7400만의 운영 현금 흐름과 $3억 5100만의 자유 현금 흐름을 창출했습니다. 순주문은 $40억에 달했으며, 책 대비 판매 비율은 1.0입니다. Leidos는 2024 회계연도 전망을 업데이트하여 조정된 EBITDA 마진을 약 12%로, 비-GAAP 희석 EPS를 $8.60-$9.00로 증가시켰습니다.

Leidos Holdings (NYSE: LDOS) a annoncé des résultats solides pour le deuxième trimestre de l'exercice 2024, avec un chiffre d'affaires en hausse de 8 % par rapport à l'année précédente, atteignant 4,1 milliards $. Le bénéfice net a augmenté de 54 % pour atteindre 324 millions $, soit 2,37 $ par action diluée. L'EBITDA ajusté a crû de 33 % pour atteindre 559 millions $, avec une marge record de 13,5 %. Le BPA dilué non-GAAP a augmenté de 46 % pour atteindre 2,63 $.

L'entreprise a généré 374 millions $ de flux de trésorerie d'exploitation et 351 millions $ de flux de trésorerie libre. Les réservations nettes ont totalisé 4,0 milliards $, ce qui a entraîné un ratio de book-to-bill de 1,0. Leidos a mis à jour ses prévisions pour l'exercice 2024, en augmentant la marge d'EBITDA ajusté à environ 12 % et le BPA dilué non-GAAP à 8,60 $ - 9,00 $.

Leidos Holdings (NYSE: LDOS) hat starke Ergebnisse für das zweite Quartal des Geschäftsjahres 2024 berichtet, mit einem Umsatzanstieg von 8% im Vergleich zum Vorjahr auf $4,1 Milliarden. Der Nettogewinn stieg um 54% auf $324 Millionen, oder $2,37 pro verwässerter Aktie. Das bereinigte EBITDA wuchs um 33% auf $559 Millionen, mit einer Rekordmarge von 13,5%. Das verwässerte EPS nach Nicht-GAAP-Kriterien erhöhte sich um 46% auf $2,63.

Das Unternehmen generierte $374 Millionen an operativem Cashflow und $351 Millionen an Freiem Cashflow. Die Nettobuchungen beliefen sich auf $4,0 Milliarden, was zu einem Verhältnis von Buch zu Rechnung von 1,0 führte. Leidos aktualisierte seine Prognose für das Geschäftsjahr 2024 und hob die bereinigte EBITDA-Marge auf etwa 12% und das Nicht-GAAPverwässerte EPS auf $8,60-$9,00 an.

Positive
  • Revenues increased 8% year-over-year to $4.1 billion
  • Net income grew 54% to $324 million
  • Adjusted EBITDA margin reached a record 13.5%, up from 10.9% in Q2 2023
  • Non-GAAP diluted EPS increased 46% to $2.63
  • Generated $374 million in operating cash flow and $351 million in free cash flow
  • Net bookings of $4.0 billion, maintaining a book-to-bill ratio of 1.0
  • Raised FY2024 guidance for adjusted EBITDA margin and non-GAAP diluted EPS
Negative
  • None.

Insights

Leidos Holdings' Q2 FY2024 results showcase impressive growth and profitability. Revenues increased by 8% year-over-year to $4.1 billion, driven by heightened demand across all customer segments, particularly in managed health services. This growth outpaces the industry average, indicating Leidos' strong market position.

The company's profitability metrics are particularly noteworthy. Net income surged by 54% to $324 million, with net income margin expanding from 5.5% to 7.8%. Adjusted EBITDA margin reached a record 13.5%, up from 10.9% in Q2 2023. This substantial margin improvement suggests effective cost management and operational efficiency.

Cash flow generation remains robust, with $374 million in operating cash flow and $351 million in free cash flow. The company's Days Sales Outstanding (DSO) improved by 1 day to 58, indicating strong collections performance and efficient working capital management.

Leidos' book-to-bill ratio of 1.0 for the quarter and 1.1 for the trailing twelve months suggests steady demand for its services. The $36.5 billion backlog provides good visibility into future revenues.

The company's updated guidance for FY2024, including higher adjusted EBITDA margin and non-GAAP EPS ranges, reflects management's confidence in sustaining this growth trajectory. However, investors should monitor potential challenges in maintaining such high growth rates and margins in the long term.

Leidos' Q2 results underscore its strong position in the defense and government services sector. The company secured several significant contract wins, demonstrating its competitive edge in critical areas of national security and technology.

The $823 million Defense Enclave Services (DES) Department of Defense Network (DoDNet) Services task order is particularly noteworthy. This five-year contract expands Leidos' support from 30,000 to over 160,000 users, with potential growth to 370,000 users. This massive scaling opportunity not only boosts revenue but also cements Leidos' role in critical defense infrastructure.

The $738 million Air Force National Capital Region IT Services contract and the $631 million U.S. Army contract for aerial intelligence systems further diversify Leidos' defense portfolio. These long-term contracts provide stable revenue streams and opportunities for technology innovation.

The $476 million NASA Cargo Mission Contract renewal highlights Leidos' expertise in space logistics, aligning with the growing commercial space sector. This positions the company well for future opportunities in both government and private space initiatives.

Leidos' ability to secure these high-value, long-term contracts across various defense and government agencies demonstrates its strong relationships and reputation in the sector. This diverse contract base provides resilience against potential budget fluctuations in any single area of government spending.

  • Revenues of $4.1 billion, up 8% year-over-year
  • Net income of $324 million or $2.37 per diluted share
  • Adjusted EBITDA (non-GAAP) of $559 million (13.5% margin)
  • Non-GAAP Diluted Earnings per Share of $2.63, up 46% year-over-year
  • Cash Flows from Operations of $374 million; Free Cash Flow (non-GAAP) of $351 million
  • Net Bookings of $4.0 billion (book-to-bill ratio of 1.0 for the quarter and 1.1 for trailing twelve months)

RESTON, Va., July 30, 2024 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS), a FORTUNE 500® innovation company, today reported financial results for the second quarter of fiscal year 2024.

Thomas Bell, Leidos Chief Executive Officer, commented, "In the second quarter, Leidos continued its industry-leading profitable growth and strong cash generation, showcasing the progress we've made towards our key operational priorities and the dedication to our "Promises Made, Promises Kept" philosophy. Our collaborative innovation strategy and capabilities-based organization position us well to deliver on our commitments for the remainder of 2024 and beyond."

Summary Operating Results




Three Months Ended

(in millions, except margin and per share data)


June 28, 2024


June 30, 2023

Revenues


$                  4,132


$                  3,838

Net income


$                     324


$                     210

Net income margin


7.8 %


5.5 %

Diluted earnings per share (EPS)


$                    2.37


$                    1.50






Non-GAAP Measures*:





Adjusted EBITDA


$                     559


$                     420

Adjusted EBITDA margin


13.5 %


10.9 %

Non-GAAP diluted EPS


$                    2.63


$                    1.80






* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another measure of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.

Revenues for the quarter were $4.13 billion, up 8% compared to the second quarter of 2023. Revenues grew year-over-year due to increased demand across all customer segments, especially for managed health services.

For the second quarter, net income was $324 million, or $2.37 per diluted share. Net income and diluted EPS were up 54% and 58% year-over-year, respectively. Net income margin of 7.8% increased from 5.5% in the second quarter of 2023.

Adjusted EBITDA was $559 million for the second quarter, up 33% year-over-year. Record adjusted EBITDA margin of 13.5% increased from 10.9% in the second quarter of 2023. Non-GAAP net income was $360 million for the second quarter, up 43% year-over-year, and non-GAAP diluted EPS for the quarter was $2.63, up 46% year-over-year. The primary drivers of increased profitability were increased volumes and higher earned incentives on managed health services and improved cost control across the company.

Cash Flow Summary

In the second quarter, Leidos generated $374 million of net cash provided by operating activities and used $21 million and $159 million in investing and financing activities, respectively. Net cash provided by operating activities was driven by strong EBITDA and collections performance. Days Sales Outstanding (DSO) for the quarter was 58, a 1-day improvement from the second quarter of 2023.

Investing activities consisted primarily of $23 million in property, equipment and software payments, which resulted in quarterly free cash flow of $351 million. Leidos returned $165 million to shareholders in the second quarter, including $114 million in share repurchases and $51 million as part of its regular quarterly cash dividend program. As of June 28, 2024, Leidos had $823 million in cash and cash equivalents and $4.7 billion of debt.

On July 26, 2024, the Leidos Board of Directors declared a cash dividend of $0.38 per share to be paid on September 27, 2024, to stockholders of record at the close of business on September 13, 2024.

Business Development

Net bookings totaled $4.0 billion in the quarter, representing a book-to-bill ratio of 1.0. As a result, backlog at the end of the quarter was $36.5 billion, of which $8.0 billion was funded. Included in the quarterly bookings were several notable awards:

  • Defense Enclave Services (DES) Department of Defense Network (DoDNet) Services. The Defense Information Systems Agency awarded Leidos a $823 million, five-year task order to provide long-term operations and sustainment for the DES DoDNet program. This award expands support from over 30,000 users to more than 160,000 users, including 14 additional Defense Agencies and Field Activities (DAFAs) to be migrated to DoDNet, and is projected to support approximately 370,000 DAFA users and workstations once complete. The work provides a more diverse and scalable service offering for the DoDNet user community, while also improving cybersecurity, network availability and reliability.
  • Air Force National Capital Region Information Technology Services Follow-On. The U.S Air Force awarded Leidos a single-award, indefinite delivery, indefinite quantity (IDIQ) contract with an estimated total value of $738 million over five years. Under the contract, Leidos will support all components of the U.S. Air Force in the national capital region and National Military Command Center, including cybersecurity, enterprise IT operations, IT asset management, program management and other engineering services.
  • Development, Integration, Acquisition, and Bridging to Logistics & Operations. The U.S. Army Contracting Command - Aberdeen Proving Grounds awarded Leidos a 10-year, $631 million contract to develop, acquire, field and provide lifecycle support to aerial intelligence, surveillance and reconnaissance sensors and integrated systems across a broad spectrum of multiple intelligence capabilities.
  • NASA Cargo Mission Contract Follow-On. Under a five-year, $476 million contract, Leidos will continue to provide cargo mission engineering and integration services for NASA's International Space Station Program and Artemis campaign. Since 2004, Leidos has performed cargo mission support work for NASA by providing analytical and physical processing, engineering maintenance and operations support, as well as developing and certifying hardware for mission objectives and supporting logistical and integration functions to maintain adequate crew provisions an supplies to sustain human presence in space.

Forward Guidance

Leidos is updating its fiscal year 2024 guidance as follows: 


FY24 Guidance

Measure

Current

Prior

Revenues (billions)

$16.1 - $16.4

$16.0 - $16.4

Adjusted EBITDA Margin

Approximately 12%

Mid-to-High 11%

Non-GAAP Diluted EPS

$8.60 - $9.00

$8.40 - $8.80

Cash Flows Provided by Operating Activities (billions)

Approximately $1.3

Approximately $1.3

For information regarding adjusted EBITDA margin and non-GAAP diluted EPS, see the related explanations and reconciliations to GAAP measures included elsewhere in this release.

Leidos does not provide a reconciliation of forward-looking adjusted EBITDA margins or non-GAAP diluted EPS to net income due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income may vary significantly based on actual events, Leidos is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected net income and diluted EPS being materially less than what may be implied by projected adjusted EBITDA margins and non-GAAP diluted EPS.

Conference Call Information

Leidos management will discuss operations and financial results in an earnings conference call beginning at 8 A.M. eastern time on July 30, 2024. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website (http://ir.leidos.com). An archived version of the webcast will be available on the Leidos Investor Relations website until July 30, 2025.

About Leidos

Leidos is a Fortune 500® innovation company rapidly addressing the world's most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $15.4 billion for the fiscal year ended December 29, 2023. For more information, visit www.leidos.com

Forward-Looking Statements

Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of our future growth, strategy and financial and operating performance, including future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about our business contingency plans, government budgets and the ongoing Continuing Resolution, uncertainties in tax due to new tax legislation or other regulatory developments, strategy, planned investments, sustainability goals and our future dividends, share repurchases, capital expenditures, debt repayments, acquisitions, dispositions and cash flow conversion. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.

Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the U.S. government budget process or a government shutdown, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; rising inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of health epidemics, pandemics and similar outbreaks may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer and disposal, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.

These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.

All information in this release is as of July 30, 2024. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

CONTACTS:






Investor Relations:


Media Relations:

Stuart Davis


Melissa Lee Dueñas

571.526.6124


571.526.6850

ir@leidos.com


Duenasml@leidos.com

 

LEIDOS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in millions, except per share data)




Three Months Ended


Six Months Ended



June 28,
2024


June 30,
2023


June 28,
2024


June 30,
2023

Revenues


$        4,132


$        3,838


$        8,107


$        7,537

Cost of revenues


3,427


3,271


6,764


6,475

Selling, general and administrative expenses


231


237


457


470

Acquisition, integration and restructuring costs


7


6


11


9

Equity earnings of non-consolidated subsidiaries


(8)


(7)


(15)


(13)

Operating income


475


331


890


596

Non-operating income (expense):









Interest expense, net


(51)


(56)


(100)


(110)

Other income (expense), net


2


(1)


4


(5)

Income before income taxes


426


274


794


481

Income tax expense


(102)


(64)


(187)


(107)

Net income


324


210


607


374

Less: net income attributable to non-controlling interest


2


3


1


5

Net income attributable to Leidos common stockholders


$           322


$           207


$           606


$           369










Earnings per share:









Basic


$          2.39


$          1.51


$          4.49


$          2.69

Diluted


2.37


1.50


4.42


2.67










Weighted average number of common shares outstanding:









Basic


135


137


135


137

Diluted


136


138


137


138










Cash dividends declared per share


$          0.38


$          0.36


$          0.76


$          0.72

 

LEIDOS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)




June 28,
2024


December 29,
2023

Assets:





Cash and cash equivalents


$           823


$           777

Receivables, net


2,615


2,429

Inventory, net


333


310

Other current assets


458


489

Total current assets


4,229


4,005

Property, plant and equipment, net


984


961

Intangible assets, net


592


667

Goodwill


6,102


6,112

Operating lease right-of-use assets, net


480


512

Other long-term assets


522


438

Total assets


$      12,909


$      12,695






Liabilities:





Accounts payable and accrued liabilities


$        2,235


$        2,277

Accrued payroll and employee benefits


703


695

Current portion of long-term debt


567


18

Total current liabilities


3,505


2,990

Long-term debt, net of current portion


4,109


4,664

Operating lease liabilities


486


516

Other long-term liabilities


299


267

Total liabilities


8,399


8,437






Stockholders' equity:





Common stock, $0.0001 par value, 500,000,000 shares authorized, 134,709,785 and
135,766,419 shares issued and outstanding at June 28, 2024, and December 29, 2023, respectively



Additional paid-in capital


1,654


1,885

Retained earnings


2,866


2,364

Accumulated other comprehensive loss


(65)


(48)

Total Leidos stockholders' equity


4,455


4,201

Non-controlling interest


55


57

Total stockholders' equity


4,510


4,258

Total liabilities and stockholders' equity


$      12,909


$      12,695

 

LEIDOS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)




Three Months Ended


Six Months Ended



June 28,
2024


June 30,
2023


June 28,
2024


June 30,
2023

Cash flows from operations:









Net income


$         324


$         210


$         607


$         374

Adjustments to reconcile net income to net cash provided by operations:









Depreciation and amortization


71


84


140


166

Stock-based compensation


20


19


40


37

Deferred income taxes


(42)


(45)


(67)


(88)

Other


8


1


2


6

Change in assets and liabilities, net of effects of acquisitions:









Receivables


96


43


(185)


(123)

Other current assets and other long-term assets


42


58


7


49

Accounts payable and accrued liabilities and other long-term liabilities


(73)


(101)


(174)


(198)

Accrued payroll and employee benefits


(38)


(45)


10


(32)

Income taxes receivable/payable


(34)


(60)


57


(125)

Net cash provided by operating activities


374


164


437


66

Cash flows from investing activities:









Acquisition of a business, net of cash acquired



(4)



(4)

Payments for property, equipment and software


(23)


(40)


(40)


(79)

Net proceeds from sale of assets


2



2


Other




5


Net cash used in investing activities


(21)


(44)


(33)


(83)

Cash flows from financing activities:









Proceeds from debt issuance





1,743

Net proceeds from commercial paper



200



200

Repayments of borrowings


(5)


(325)


(9)


(2,036)

Payments for debt issuance costs





(7)

Dividend payments


(51)


(50)


(104)


(100)

Repurchases of stock and other


(114)



(297)


(43)

Proceeds from issuances of stock


13


13


26


25

Net capital distributions to non-controlling interests


(2)


(2)


(3)


(3)

Net cash used in financing activities


(159)


(164)


(387)


(221)

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash



1


(4)


3

Net increase (decrease) in cash, cash equivalents and restricted cash


194


(43)


13


(235)

Cash, cash equivalents and restricted cash at beginning of period


747


491


928


683

Cash, cash equivalents and restricted cash at end of period


941


448


941


448

Less: restricted cash at end of period


118


119


118


119

Cash and cash equivalents at end of period


$         823


$         329


$         823


$         329

 

LEIDOS HOLDINGS, INC.

UNAUDITED SEGMENT OPERATING RESULTS

(in millions)




Three Months Ended


Six Months Ended



June 28,
2024


June 30,
2023


June 28,
2024


June 30,
2023

Revenues:









National Security and Digital


$     1,813


$     1,791


$       3,606


$       3,548

Health & Civil


1,263


1,034


2,462


2,042

Commercial & International


561


547


1,070


1,036

Defense Systems


495


466


969


911

Total


$     4,132


$     3,838


$       8,107


$       7,537










Operating income (loss):









National Security and Digital


$        183


$        172


$          358


$          317

Health & Civil


307


134


529


247

Commercial & International


(11)


34


23


47

Defense Systems


34


21


55


44

Corporate


(38)


(30)


(75)


(59)

Total


$        475


$        331


$          890


$          596










Operating income margin:









National Security and Digital


10.1 %


9.6 %


9.9 %


8.9 %

Health & Civil


24.3 %


13.0 %


21.5 %


12.1 %

Commercial & International


(2.0) %


6.2 %


2.1 %


4.5 %

Defense Systems


6.9 %


4.5 %


5.7 %


4.8 %

Total


11.5 %


8.6 %


11.0 %


7.9 %

National Security and Digital

National Security and Digital revenues of $1.81 billion increased by 1% compared to the prior year quarter. Revenue growth reflects increased volumes on the Sentinel contract, DES program and several contracted research and development efforts. For the quarter, operating income margin increased to 10.1% from 9.6% in the prior year quarter, and non-GAAP operating income margin increased to 10.4% from 10.2% in the prior year quarter. The increase in segment profitability was primarily attributable to volume and efficiencies on certain fixed price programs.

Health & Civil

Health & Civil revenues of $1.26 billion increased by 22% compared to the prior year quarter. Health & Civil operating income margin for the quarter was 24.3%, compared to 13.0% in the prior year quarter, and non-GAAP operating income margin was 24.9%, compared to 14.0% in the prior year quarter. The increase in revenues and segment profitability was driven by increased volumes and case complexity and better incentive performance within the managed health services business.

Commercial & International

Commercial & International revenues of $561 million increased by 3% compared to the prior year quarter driven by increased deliveries of security products and higher volumes within the commercial energy and Australian IT businesses, partially offset by the impact of rebaselining certain contracts within the United Kingdom (UK) business. Operating income margin for the quarter was (2.0)%, compared to 6.2% in the prior year quarter, and non-GAAP operating margin was 0.7%, compared to 8.2% in the prior year quarter. The decrease in segment profitability was driven by the UK contract adjustments.

Defense Systems

Defense Systems revenues of $495 million increased by 6% compared to the prior year quarter, primarily driven by increased volumes within the airborne surveillance and reconnaissance and hypersonics businesses. Defense Systems operating income margin for the quarter was 6.9%, compared to 4.5% in the prior year quarter, and non-GAAP operating margin was 10.3%, compared to 8.6% in the prior year quarter. The increase in segment profitability is primarily attributable to improved program execution compared to the prior year period.

LEIDOS HOLDINGS, INC.
UNAUDITED BACKLOG BY REPORTABLE SEGMENT
(in millions)

Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts. Backlog value is based on management's estimates about volume of services, availability of customer funding and other factors, and excludes contracts that are under protest. Estimated backlog comprises both funded and negotiated unfunded backlog. Backlog estimates are subject to change and may be affected by several factors, including modifications of contracts, non-exercise of options and foreign currency movements.

Funded backlog for contracts with the U.S. government represents the value on contracts for which funding is appropriated less revenues previously recognized on these contracts. Funded backlog for contracts with non-U.S. government entities and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which Leidos is obligated to perform, less revenue previously recognized on the contracts.

Negotiated unfunded backlog represents estimated amounts of revenue to be earned in the future from contracts for which funding has not been appropriated and unexercised priced contract options. Negotiated unfunded backlog does not include unexercised option periods and future potential task orders expected to be awarded under IDIQ, General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded or separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future anticipated task orders.

The estimated value of backlog as of the dates presented was as follows:



June 28, 2024


June 30, 2023

Segment


Funded


Unfunded


Total


Funded


Unfunded


Total

National Security and Digital


$        2,681


$      15,268


$      17,949


$        2,806


$      12,549


$      15,355

Health & Civil


1,607


8,837


10,444


1,635


9,127


10,762

Commercial & International


2,699


1,886


4,585


2,786


972


3,758

Defense Systems


1,036


2,473


3,509


1,045


3,232


4,277

Total


$        8,023


$      28,464


$      36,487


$        8,272


$      25,880


$      34,152

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES

Leidos uses and refers to organic revenue, non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP diluted EPS, non-GAAP free cash flow and non-GAAP free cash flow conversion, which are not measures of financial performance under generally accepted accounting principles in the U.S. and, accordingly, these measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in conjunction with Leidos's consolidated financial statements prepared in accordance with GAAP.

Management believes that these non-GAAP measures provide another representation of the results of operations and financial condition, including its ability to comply with financial covenants. These non-GAAP measures are frequently used by financial analysts covering Leidos and its peers. The computation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies, thus limiting their use for comparability.

Organic revenues capture the revenue that is inherent in the underlying business excluding the impact of acquisitions and divestitures made within the prior year; it is computed as current revenues excluding revenues from acquisitions within the last 12 months and divestitures within the current and year-ago periods.

Non-GAAP operating income is computed by excluding the following discrete items from operating income:

  • Acquisition, integration and restructuring costs – Represents acquisition, integration, lease termination, severance and retention costs and asset markdowns related to acquisitions and restructuring activities.
  • Amortization of acquired intangible assets – Represents the amortization of the fair value of the acquired intangible assets.
  • Gain on sale of intangible assets – Represents the gain on sale of intellectual property not used in operations.

Non-GAAP operating margin is computed by dividing non-GAAP operating income by revenues.

Adjusted EBITDA is computed by excluding the following items from income before income taxes: (i) discrete items as identified above; (ii) interest expense; (iii) interest income; (iv) depreciation expense; and (v) amortization of internally developed intangible assets.

Adjusted EBITDA margin is computed by dividing adjusted EBITDA by revenues.

Non-GAAP net income is computed by excluding the discrete items listed under non-GAAP operating income and their related tax impacts.

Non-GAAP diluted EPS is computed by dividing net income attributable to Leidos common stockholders, adjusted for the discrete items as identified above and the related tax impacts, by the diluted weighted average number of common shares outstanding.

Non-GAAP free cash flow is computed by deducting expenditures for property, equipment and software from net cash provided by (used in) operating activities.

Non-GAAP free cash flow conversion is computed by dividing non-GAAP free cash flow by non-GAAP net income attributable to Leidos common stockholders; operating cash flow conversion is computed by dividing net cash provided by (used in) operating activities by net income attributable to Leidos shareholders.

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except growth percentages)

The following table presents the reconciliation of revenues to organic revenues by reportable segment and total operations:



Three Months Ended





June 28,
2024


June 30,
2023


Percent Change

National Security and Digital







Revenues, as reported


$           1,813


$           1,791


1 %








Health & Civil







Revenues, as reported


$           1,263


$           1,034


22 %








Commercial & International







Revenues, as reported


$             561


$             547


3 %








Defense Systems







Revenues, as reported


$             495


$             466


6 %

Acquisition and divestiture revenues(1)



2



Organic revenues


$             495


$             464


7 %








Total Operations 







Revenues, as reported


$           4,132


$           3,838


8 %

Acquisition and divestiture revenues(1)



2



Organic revenues


$           4,132


$           3,836


8 %


(1) Year ago acquisition and divestiture revenues reflect revenues from assets subsequently divested. For the three months ended June 30, 2023, Defense Systems segment acquisition and divestiture revenues include the divestiture of an immaterial asset that was completed on October 20, 2023.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended June 28, 2024: 



Three Months Ended June 28, 2024



As reported


Acquisition,
integration
and
restructuring
costs(3)


Amortization
of acquired
intangibles


Gain on sale
of intangible
assets


Non-GAAP
results

Operating income


$           475


$           13


$           36


$           —


$         524

Non-operating expense, net


(49)




(2)


(51)

Income before income taxes


426


13


36


(2)


473

Income tax expense(1)


(102)


(3)


(8)



(113)

Net income


324


10


28


(2)


360

Less: net income attributable to non-controlling interest


2





2

Net income attributable to Leidos common stockholders


$           322


$           10


$           28


$           (2)


$         358












Diluted EPS attributable to Leidos common stockholders(2)


$          2.37


$        0.07


$        0.21


$      (0.01)


$        2.63

Diluted shares


136


136


136


136


136




Three Months Ended June 28, 2024



As reported


Acquisition,
integration
and
restructuring
costs(3)


Amortization
of acquired
intangibles


Gain on sale
of intangible
assets


Non-GAAP
results

Net income


$        324


$           10


$           28


$           (2)


$        360

Income tax expense(1)


102


3


8



113

Income before income taxes


426


13


36


(2)


473

Depreciation expense


35





35

Amortization of intangibles


36



(36)



Interest expense, net


51





51

Adjusted EBITDA


$        548


$           13


$           —


$           (2)


$        559

Adjusted EBITDA margin


13.3 %








13.5 %


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

(3) Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended June 30, 2023:



Three Months Ended June 30, 2023



As reported


Acquisition,
integration
and
restructuring
costs


Amortization
of acquired
intangibles


Non-GAAP
results

Operating income


$           331


$              6


$            51


$           388

Non-operating expense, net


(57)




(57)

Income before income taxes


274


6


51


331

Income tax expense(1)


(64)


(2)


(13)


(79)

Net income


210


4


38


252

Less: net income attributable to non-controlling interest


3




3

Net income attributable to Leidos common stockholders


$           207


$              4


$            38


$           249










Diluted EPS attributable to Leidos common stockholders(2)


$          1.50


$          0.03


$          0.28


$          1.80

Diluted shares


138


138


138


138




Three Months Ended June 30, 2023



As reported


Acquisition,
integration
and
restructuring
costs


Amortization
of acquired
intangibles


Non-GAAP
results

Net income


$          210


$              4


$            38


$          252

Income tax expense(1)


64


2


13


79

Income before income taxes


274


6


51


331

Depreciation expense


33




33

Amortization of intangibles


51



(51)


Interest expense, net


56




56

Adjusted EBITDA


$          414


$              6


$             —


$          420

Adjusted EBITDA margin


10.8 %






10.9 %


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended June 28, 2024:



Six Months Ended June 28, 2024



As reported


Acquisition,
integration
and
restructuring
costs(3)


Amortization

 of acquired
intangibles


Gain on sale
of intangible
assets


Non-GAAP
results

Operating income


$         890


$           17


$           73


$           —


$         980

Non-operating expense, net


(96)




(2)


(98)

Income before income taxes


794


17


73


(2)


882

Income tax expense(1)


(187)


(4)


(18)



(209)

Net income


607


13


55


(2)


673

Less: net income attributable to non-controlling interest


1





1

Net income attributable to Leidos common stockholders


$         606


$           13


$           55


$           (2)


$         672












Diluted EPS attributable to Leidos common stockholders(2)


$        4.42


$        0.09


$        0.40


$      (0.01)


$        4.91

Diluted shares


137


137


137


137


137






Six Months Ended June 28, 2024



As reported


Acquisition,
integration
and
restructuring
costs(3)


Amortization
of acquired
intangibles


Gain on sale
of intangible
assets


Non-GAAP
results

Net income


$        607


$           13


$           55


$           (2)


$        673

Income tax expense(1)


187


4


18



209

Income before income taxes


794


17


73


(2)


882

Depreciation expense


67





67

Amortization of intangibles


73



(73)



Interest expense, net


100





100

Adjusted EBITDA


$     1,034


$           17


$           —


$           (2)


$     1,049

Adjusted EBITDA margin


12.8 %








12.9 %


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

(3) Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended June 30, 2023: 



Six Months Ended June 30, 2023



As reported


Acquisition,
integration
and
restructuring
costs


Amortization
of acquired

 intangibles


Non-GAAP

 results

Operating income


$           596


$              9


$           103


$           708

Non-operating expense, net


(115)




(115)

Income before income taxes


481


9


103


593

Income tax expense(1)


(107)


(2)


(27)


(136)

Net income


374


7


76


457

Less: net income attributable to non-controlling interest


5




5

Net income attributable to Leidos common stockholders


$           369


$              7


$            76


$           452










Diluted EPS attributable to Leidos common stockholders(2)


$          2.67


$          0.05


$          0.55


$          3.28

Diluted shares


138


138


138


138




Six Months Ended June 30, 2023



As reported


Acquisition,
integration

 and
restructuring
costs


Amortization
of acquired
intangibles


Non-GAAP
results

Net income


$          374


$              7


$            76


$          457

Income tax expense(1)


107


2


27


136

Income before income taxes


481


9


103


593

Depreciation expense


63




63

Amortization of intangibles


103



(103)


Interest expense, net


110




110

Adjusted EBITDA


$          757


$             9


$            —


$          766

Adjusted EBITDA margin


10.0 %






10.2 %


(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.

(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except margin percentages)

The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:



Three Months Ended June 28, 2024



Operating
income (loss)


Acquisition,
integration and
restructuring
costs


Amortization
 of acquired
intangibles


Non-GAAP
operating
income (loss)


Non-GAAP
operating
margin

National Security and Digital


$           183


$             —


$              5


$           188


10.4 %

Health & Civil


307



7


314


24.9 %

Commercial & International


(11)


8


7


4


0.7 %

Defense Systems


34



17


51


10.3 %

Corporate


(38)


5



(33)


NM

Total


$           475


$            13


$            36


$           524


12.7 %






Three Months Ended June 30, 2023



Operating
income (loss)


Acquisition,
integration and
restructuring
costs


Amortization
of acquired
intangibles


Non-GAAP
operating
income
(loss)


Non-GAAP
operating margin

National Security and Digital


$           172


$             —


$            11


$           183


10.2 %

Health & Civil


134



11


145


14.0 %

Commercial & International


34


1


10


45


8.2 %

Defense Systems


21



19


40


8.6 %

Corporate


(30)


5



(25)


NM

Total


$           331


$              6


$            51


$           388


10.1 %






Six Months Ended June 28, 2024



Operating
income (loss)


Acquisition,
integration and
restructuring
costs


Amortization
 of acquired
intangibles


Non-GAAP
operating
income
(loss)


Non-GAAP
operating margin

National Security and Digital


$           358


$             —


11


$           369


10.2 %

Health & Civil


529



13


542


22.0 %

Commercial & International


23


8


15


46


4.3 %

Defense Systems


55



34


89


9.2 %

Corporate


(75)


9



(66)


NM

Total


$           890


$            17


$            73


$           980


12.1 %






Six Months Ended June 30, 2023



Operating
income (loss)


Acquisition,
integration and
restructuring
costs


Amortization
of acquired
intangibles


Non-GAAP
operating
income
(loss)


Non-GAAP
operating margin

National Security and Digital


$           317


$             —


$            23


$           340


9.6 %

Health & Civil


247



21


268


13.1 %

Commercial & International


47


1


20


68


6.6 %

Defense Systems


44



39


83


9.1 %

Corporate


(59)


8



(51)


NM

Total


$           596


$              9


$           103


$           708


9.4 %


NM - Not Meaningful

 

LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except percentages)

The following table presents the reconciliation of non-GAAP free cash flow to net cash provided by operating activities as well as the calculation of operating cash flow and non-GAAP free cash flow conversion ratios:



Three Months Ended



June 28, 2024


June 30, 2023

Net cash provided by operating activities


$                 374


$                 164

Payments for property, equipment and software


(23)


(40)

Non-GAAP free cash flow


$                 351


$                 124






Net income attributable to Leidos common stockholders


$                 322


$                 207

Acquisition, integration and restructuring costs(1)


10


4

Amortization of acquired intangibles(1)


28


38

Gain on sale of intangible assets


(2)


Non-GAAP net income attributable to Leidos common stockholders


$                 358


$                 249






Operating cash flow conversion ratio


116 %


79 %

Non-GAAP free cash flow conversion ratio


98 %


50 %


(1) After-tax expenses excluded from non-GAAP net income.

 

Cision View original content:https://www.prnewswire.com/news-releases/leidos-holdings-inc-reports-second-quarter-fiscal-year-2024-results-302208934.html

SOURCE Leidos

FAQ

What were Leidos Holdings' (LDOS) Q2 2024 revenue and earnings?

Leidos Holdings reported Q2 2024 revenues of $4.1 billion, up 8% year-over-year. Net income was $324 million, or $2.37 per diluted share, representing a 54% increase from the previous year.

How did Leidos' (LDOS) adjusted EBITDA perform in Q2 2024?

Leidos' adjusted EBITDA for Q2 2024 was $559 million, up 33% year-over-year. The adjusted EBITDA margin reached a record 13.5%, increasing from 10.9% in Q2 2023.

What was Leidos Holdings' (LDOS) book-to-bill ratio in Q2 2024?

Leidos Holdings reported net bookings of $4.0 billion in Q2 2024, resulting in a book-to-bill ratio of 1.0 for the quarter.

Has Leidos (LDOS) updated its financial guidance for FY2024?

Yes, Leidos updated its FY2024 guidance, raising the adjusted EBITDA margin to approximately 12% and non-GAAP diluted EPS to $8.60-$9.00. Revenue guidance remained at $16.1-$16.4 billion.

Leidos Holdings, Inc.

NYSE:LDOS

LDOS Rankings

LDOS Latest News

LDOS Stock Data

21.79B
135.21M
1.09%
79.44%
1.06%
Information Technology Services
Services-computer Integrated Systems Design
Link
United States of America
RESTON